Critical Illness
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18 or older; 2.Blood glucose and vital signs need to be monitored; 3.Patients participate in the trial voluntarily, and either the patient or a family member signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients diagnosed with liver or kidney disease; 2.Patients for whom the intended measurement site is not suitable for the non-invasive blood glucose monitoring prototype; 3.Patients currently taking non-antidiabetic medications that affect blood sugar levels; 4.Patients with elevated hematocrit levels, edema, dehydration, or those taking high doses of vitamin C; 5.Patients who refuse to sign a written informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean monitoring error of noninvasive blood glucose prediction models.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity; | — |
Countries
China
Contacts
Chongqing University Cancer Hospital